Prevention and treatment of osteoporosis during treatment of non-metastatic prostate cancer
Eiken, P.A.; Langdahl, B.L.; Eiken, F.L.; Walter, S.; Poulsen, M.Hvid.; Abrahamsen, B.
Ugeskrift for Laeger 173(48): 3093-3096
2011
ISSN/ISBN: 0041-5782 PMID: 22118650 Document Number: 655626
The prevention of cancer treatment-induced bone loss in patients with prostate cancer due to gonadotropin-releasing hormone (GnRH)-agonist, GnRH-antagonist and orchidectomi therapy has a high priority. We present an algorithm for the prevention and treatment of osteoporosis during treatment of non-metastatic prostate cancer.
Document emailed within 1 workday
Related Documents
Matzkin, H.; Braf, Z. 1994: Complete androgen blockage in the treatment of metastatic prostate cancer Harefuah 126(5): 260-263Simonin, R.; Nicolino-Peltier, C.; Gainlet, P. 1989: Gonadorelin analogs combined with anti-androgens in the treatment of bone metastasis from prostate cancer. can their use induce osteoporosis? Presse Medicale 18(41): 2023
Ecstein-Fraisse, E.; Su, Z. 2014: Cabazitaxel--a next-generation taxane for the treatment of patients with metastatic castration-resistant prostate cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(7): 817-822
Amsellem-Ouazana, D.; Conquy, S. 2004: Diet and prostate cancer: from prevention to treatment Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 14(4): 573-576
Abbou, C.C.; Lucas, C.; Leblanc, V. 1997: Tolerance and clinical and biological responses during the first 6 months of treatment with 1-month sustained release LHRH agonists leuprolerin and triptolerin in patients with metastatic prostate cancer Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(6): 984-995
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
Leewansangtong, S.; Soontrapa, S. 2003: The pattern of prostate-specific antigen responses following hormonal therapy in Thai men with bone metastatic prostate cancer Journal of the Medical Association of Thailand 86(9): 809-815
Nakagawa, H.; Hagiwara, Y.; Yamada, M.; Moriuchi, S.; Iwatsuki, K.; Nakamura, S.; Hourai, T. 1997: Treatment of metastatic brain tumors from lung cancer: analysis of performance status between treatment methods No Shinkei Geka. Neurological Surgery 25(2): 117-122
Nakanishi, K.; Ueno, Y.; Nakamura, N.; Yoshikawa, H.; Takeuchi, T.; Tanihata, H.; Masuda, M.; Terada, M.; Satoh, M.; Okamoto, E. 1999: Successful treatment of metastatic bone cancer from colon with combination treatment (radiation and 5-FU); a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(3): 353-356
Horiguchi, A.; Hatakeyama, N.; Ikeuchi, K. 1999: Dynamics of prostate-specific antigen as prognostic factors in endocrine treatment for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 45(1): 31-35
Habib, F.K.; Ross, M.; Bayne, C.W. 1999: Factors controlling the expression of 5alpha-reductase in human prostate: A possible new approach for the treatment of prostate cancer European Urology 35(5-6): 439-442
Rébillard, X.; Davin, J-Louis.; Soulié, M. 2003: Treatment by HIFU of prostate cancer: survey of literature and treatment indications Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 13(6): 1428-1456
Fuchsjäger, M.; Akin, O.; Shukla-Dave, A.; Pucar, D.; Hricak, H. 2009: The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer Clinical Advances in Hematology and Oncology: H&o 7(3): 193-202
Boccardo, F.; Pace, M. 1993: Endocrine treatment of prostate cancer: standard treatment and new perspectives In Vivo 7(5): 423-424
Lindsay, R. 1989: Estrogens in prevention and treatment of osteoporosis Schweizerische Medizinische Wochenschrift 119(50): 1806-1810
1986: Osteoporosis. Module 2. Prevention and treatment American Pharmacy 26(11): 47-50
Jager, P.L.; Mensink, H.J.; van den Bergh, A.C.; Piers, D.A. 1999: A strontium-89 injection: a simple treatment of painful bone metastases in patients with prostate cancer unresponsive to hormonal treatment Nederlands Tijdschrift Voor Geneeskunde 143(19): 969-973
Bell, N.H.; Termine, J.D. 2001: Treatment and prevention of osteoporosis: future directions Journal of the South Carolina Medical Association 97(3): 99-101
Harada, A. 2006: Exercise for fall prevention and osteoporosis treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 64(9): 1687-1691
Korsić, M. 1990: A rational approach to the prevention and treatment of osteoporosis Lijecnicki Vjesnik 112(5-6): 198-200